Search
Treatment Settings
Various treatment formats, either in a live-in facility or through regular visits to a clinic, are designed for ongoing support, to help maintain recovery, and to prevent relapse.
Supporting Nurse Mentors to Reduce the Barriers to Implementing Alcohol Interventions and Brief Advice (IBA) in Primary Care
Key Findings
- The findings of this project suggest that providing a relatively low level of support to nurse mentors based in primary care leads to a significant increase in the delivery of IBA.
- There was a marked increase in the...
How Do People with Mood and Anxiety Disorders Perceive and Interpret the Drinking Motives Questionnaire?
Abstract
Background
Research has identified drinking motives as the final common pathway to alcohol use, and associations between specific drinking motives and drinking patterns have consistently been demonstrated. Data on drinking...
Effectiveness Bank Matrix Cell: Bridging the Chasm; Legal Drug Prescribers Relating to Illegal Drug Users
In 1960s Britain a chasm of opposing agendas and social distance opened up between doctors treating drug addiction and their patients. This cell of the Drug Treatment Matrix examines how bridging such chasms makes treatment more effective...
A Randomized, Open Label Trial of Methadone Continuation versus Forced Withdrawal in a Combined US Prison and Jail
Effectiveness Bank Analysis: Keep Maintaining Opiate-Dependent Prisoners
From the USA, a rare randomised trial found in favour of continuing methadone maintenance when patients entered prison rather than compulsory withdrawal. The...
Stressful Experiences Affect Likelihood of Remission of Drug Dependence, Continued Drug Use, and Relapse
Researchers at the University of Michigan’s Centre for the Study of Drugs, Alcohol, Smoking and Health have been exploring the link between drug dependence, ongoing drug use, relapse and exposure to stress or experience of stressful events...
Treatment for Opioid Use and Outcomes in Older Adults: A Systematic Literature Review
A new study published in the Drug and Alcohol Dependence journal focuses on an often-neglected topic – opioid use in older adults. This systematic literature review, Treatment for Opioid Use and Outcomes in Older Adults, included 76 papers...
Research Suggests Changes to the Way Opioids Are Prescribed after Surgery Could Prevent Misuse
A team of researchers from Harvard Medical School in Boston has published a new study suggesting changes to the way opioids are prescribed after surgery could be a way to reduce misuse.
Featured in the British Medical Journal, the study Po...
New from SAMHSA: Medications for Opioid Use Disorders
SAMHSA has released a new publication as part of the Treatment Improvement Protocol series.
Repeated Exposure to the “Spice” Cannabinoid JWH-018 Induces Tolerance and Enhances Responsiveness to 5-HT1A Receptor Stimulation in Male Rats
Naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) is a synthetic compound found in psychoactive “spice” products that activates cannabinoid receptors. Preclinical evidence suggests that exposure to synthetic cannabinoids increases 5...
National Trends in Alcohol Consumption in Mexico
Abstract:
Introduction: Worldwide, binge drinking of alcohol has increased, especially among young people. In Mexico, various epidemiological sources allow us to account for the growth this pattern of consumption has had. Given this...
The Influence of Hazardous Drinking on Psychological Functioning, Stress and Sleep during and after Treatment in Patients with Mental Health Problems
Abstract
Objectives: Hazardous drinking could negatively affect health and lead to alcohol use disorders, but it is unclear how hazardous drinking affects treatment outcomes of depression and anxiety and stress-related mental health...
Guide to treatment and social integration in the field of addictions
The aim of this guide is to facilitate the understanding of the problem of adolescent substance use, as well as present practices based on clinical evidence more effective guidance and intervention with this population.
The guide is...
Nabiximols Combined with Motivational Enhancement/Cognitive Behavioral Therapy for the Treatment of Cannabis Dependence
Abstract
Background
The current lack of pharmacological treatments for cannabis use disorder (CUD) warrants novel approaches and further investigation of promising pharmacotherapy. We previously showed that nabiximols (27 mg/ml Δ9...
Measuring Treatment Outcomes in Gambling Disorders
Abstract
Background and Aims
Considerable variation of outcome variables used to measure recovery in the gambling treatment literature has precluded effective cross-study evaluations and hindered the development of best-practice treatment...
Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment
Abstract
Objective
Incidence of neonatal abstinence syndrome (NAS) is increasing due to the rise in opioid use. Rural states like Kentucky have been disproportionally impacted by opioid abuse, and this study determines NAS burden...
Contemporary Routes of Cannabis Consumption: A Primer for Clinicians
Abstract
Although cannabis use is federally prohibited, medical cannabis is legal in some form in 30 states and the District of Columbia, and recreational use is legal in 8 states and the District of Columbia. The increasing legal...
Reported Theory Use by Digital Interventions for Hazardous and Harmful Alcohol Consumption, and Association with Effectiveness
ABSTRACT
Background: Applying theory to the design and evaluation of interventions is likely to increase effectiveness and improve the evidence base from which future interventions are developed, though few interventions report this.
Obje...
Effectiveness Bank Matrix Cell: Can Medications Make It *Too* Easy to Recover?
Drug-based treatments dominate opiate addiction treatment but are far from universally accepted. Referring to chemical ‘solutions’ to addiction, the ‘bite’ commentary on this cell ends with the “curious possibility that precisely because a...
Intervention guide mhGAP for mental, neurological disorders and substance use in the level of non-specialized health care. Version 2.0
Mental, neurological and substance (MNS) disorders are very common and represent a large burden of disease and disability around the world. There remains a wide gap between the capacity of health systems and resources, between what is...
mhGAP Intervention Guide - Version 2.0 for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings
Overview
This is the second version (2016) of the mhGAP Intervention Guide (mhGAP-IG) for mental, neurological and substance use (MNS) disorders in non-specialist health settings. It is for use by doctors, nurses, other health workers as...
